JT
ABBV icon

Jupiter Topco’s AbbVie ABBV Stock Holding History

Jupiter Topco’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56B Buy
+6,201,973
New +$1.33B 0.64% 31

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jupiter Topco's ABBV Position: Q2 2026 in Review

Jupiter Topco opened a new position in AbbVie (ABBV) in Q2 2026: 6,201,973 shares worth $1.56B. The stake represents 0.64% of the portfolio and ranks #31 among its holdings.

4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Jupiter Topco held 6,201,973 shares of AbbVie worth $1.56B as of Q2 2026.
  • AbbVie was a new Jupiter Topco position in Q2 2026.
  • AbbVie made up 0.64% of Jupiter Topco's portfolio in Q2 2026, its #31 holding.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.